Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 2

1(20.0%)

Phase 4

1(20.0%)

5Total

N/A(3)

Phase 2(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT04665791Not ApplicableCompleted

A Human Controlled Infection Study with Neisseria Lactamica in Malian Adults

Role: lead

NCT06047821Active Not Recruiting

Enterics for Global Health (EFGH)

Role: collaborator

NCT05409261Phase 2Active Not Recruiting

Evaluation of the Immunogenicity and Safety of Ad26.COV2.S's COVID-19 Vaccine

Role: collaborator

NCT05312242Not ApplicableCompleted

Introduction of MMS to Antenatal Care in Bamako, Mali

Role: collaborator

NCT03944551Not ApplicableTerminated

Bubble Continuous Positive Airway Pressure for Children With Severe Pneumonia in Mali, Africa

Role: collaborator

NCT02286895Phase 4Completed

Immune Response to Rotavirus Vaccine After a Supplemental Dose Given at 9 Months of Age With Local EPI Vaccines in Mali

Role: collaborator

All 6 trials loaded